Clinical Trial

High Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes.

Completed
View on ClinicalTrials.gov →
Summary
Diabetes Mellitus (DM), a chronic metabolic disease-causing chronic hyperglycemia. Globally more than 90% cases are of type II diabetes mellitus (T2DM). Around 537 million adults worldwide had diabetes but according to data from Pakistan, female sufferers are marginally higher (26.4%) as compared to men (25.1%). The main causes of DM II are genetic predispositions, including consanguinity, dietary changes, urbanization and sedentary lifestyles. It is reported that postmenopausal status is linked to worsened glycemic control, increased visceral adiposity and and inflammation, and women before menopause generally have improved lipid metabolism and insulin sensitivity. HIIT provides powerful and time-efficient benefits by alternating high-intensity workouts (85-95% HR\_Max) with recovery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Status change: Recruiting → Completed 2026-04-02
Trial Details
NCT Number NCT07258316
Lead Sponsor Riphah International University
Conditions Diabetes Mellitus, Type 2, Postmenopausal Symptoms
Enrollment 60 participants
Start Date 2025-09-25
Primary Completion 2026-03-25 (estimated)
Study Completion 2026-03-25 (estimated)
Updated on ClinicalTrials.gov 2026-04-03